Christopher G. Hayes - Jul 11, 2022 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
VRCA
Transactions as of
Jul 11, 2022
Transactions value $
$25,500
Form type
4
Date filed
7/11/2022, 05:24 PM
Previous filing
Jul 5, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Purchase $25.5K +7.5K +91.31% $3.40 15.7K Jul 11, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.